These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12271964)

  • 1. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
    Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
    Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of food on the bioavailability of isoniazid in health volunteers].
    Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 1998; 66(7-8):412-21. PubMed ID: 10354690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
    Cordes H; Thiel C; Aschmann HE; Baier V; Blank LM; Kuepfer L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6134-45. PubMed ID: 27480867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid acetylation metabolic ratio during maturation in children.
    Pariente-Khayat A; Rey E; Gendrel D; Vauzelle-Kervroëdan F; Crémier O; d'Athis P; Badoual J; Olive G; Pons G
    Clin Pharmacol Ther; 1997 Oct; 62(4):377-83. PubMed ID: 9357388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2.
    Kubota R; Ohno M; Hasunuma T; Iijima H; Azuma J
    Eur J Clin Pharmacol; 2007 Oct; 63(10):927-33. PubMed ID: 17665185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Jing W; Zong Z; Tang B; Wang J; Zhang T; Wen S; Xue Y; Chu N; Zhao W; Huang H
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
    Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
    Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
    Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
    Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment.
    Keller GA; Fabian L; Gomez M; Gonzalez CD; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):292-302. PubMed ID: 24447650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
    Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
    Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
    Parkin DP; Vandenplas S; Botha FJ; Vandenplas ML; Seifart HI; van Helden PD; van der Walt BJ; Donald PR; van Jaarsveld PP
    Am J Respir Crit Care Med; 1997 May; 155(5):1717-22. PubMed ID: 9154882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population screening for isoniazid acetylator phenotype.
    Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ
    Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.
    Wang P; Shehu AI; Lu J; Joshi RH; Venkataramanan R; Sugamori KS; Grant DM; Zhong XB; Ma X
    Biochem Pharmacol; 2017 Dec; 145():218-225. PubMed ID: 28888949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
    Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY
    Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.